NOV 06, 2019 1:30 PM PST

Impact of the cobas Liat® Flu Assay on Clinical Decision Making in the Emergency Department Setting (Clade Study Group)

Presented at: Influenza 2019
C.E. Credits: Florida CE P.A.C.E. CE
Speaker
  • Assistant Professor, Division of Infectious Diseases, Department of Pathology & Laboratory Medicine, University of Minnesota, and Director of Clinical Microbiology, Hennepin Medical Center
    BIOGRAPHY

Abstract

Respiratory viral infections remain a leading cause of medical visits and can contribute significantly to morbidity and mortality. Influenza, together with pneumonia, is the leading infectious cause of death in Canada and the United States, and is of particular concern especially in individuals with secondary risk factors. As "influenza season" approaches each year, hospitals and healthcare organizations review and update testing algorithms in attempts to maximize clinical useful testing, staffing issues, sensitivity, and rising health care costs. Despite decades of diagnostic research into laboratory and clinic based influenza testing, no one single diagnostic algorithm has emerged as a one size-fits-all strategy. Clinical decision making and subsequent patient management for patients who present to busy emergency departments during flu season is not always straight forward. Recently the COBAS LIAT Influenza assay was recently approved by the FDA for diagnosis of Influenza A/B virus. The test represents among the first truly rapid multiplex molecular PCR-based assays that can simultaneously detect and discriminate influenza A and influenza B RNA in nasopharyngeal specimens. While the prospects of reliable rapid influenza diagnostics have been examined before, few studies have attempted to correlate in real time the immediate impact of influenza assays, and no study assessing the clinical utility of LIAT during influenza season has been performed to date. Objectives: 1. Introduce the historical challenges of test options for influenza testing in hospital settings 2. Describe the performance and test characteristics of the Cobas® Liat influenza A/B assay on emergency department patients who presented with influenza-like-illness during the 2015 influenza season 3. Demonstrate the impact that rapid reliable influenza testing within emergency department settings have on patient management


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUN 22, 2021 10:00 AM PDT
C.E. CREDITS
JUN 22, 2021 10:00 AM PDT
Date: June 22, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Antimicrobial resistance (AMR) has emerged as one of the principal public health problems of the 21st century. It threatens the effectiv...
NOV 06, 2019 1:30 PM PST

Impact of the cobas Liat® Flu Assay on Clinical Decision Making in the Emergency Department Setting (Clade Study Group)

Presented at: Influenza 2019
C.E. Credits: Florida CE P.A.C.E. CE

Specialty

Molecular Biology

Infectious Disease

Microbiology

Clinical Diagnostics

Molecular Diagnostics

Laboratory Testing

Diagnostics

Genetics

Pcr/rt-Pcr/real-Time Pcr

Immunology

Biotechnology

Cell Biology

Biochemistry

Gene Expression

Disease

Geography

North America68%

Asia32%

Registration Source

Website Visitors89%

Email Promotions11%

Job Title

Medical Laboratory Technician44%

Research Scientist13%

Educator/Faculty13%

Clinical Laboratory Scientist6%

Facility/Department Manager6%

Microbiologist6%

Veterinarian6%

Scientist6%

Organization

Clinical Laboratory32%

Academic Institution21%

Hospital11%

Medical School5%

General Laboratory5%

Veterinary School5%

Government5%

Medical Center5%

Manufacturer - Other5%

Biotech Company5%


Show Resources
Loading Comments...
Show Resources